UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

Understanding how doctoral researchers perceive research supervision to impact their mental health and well‐being

Counselling and psychotherapy research, 2024-04

2024

Volltextzugriff (PDF)

Decolonising the Psychology Curriculum: A Toolkit Approach

Culturally Sensitive Curricula Scales, 2024, p.79-93

2024

Volltextzugriff (PDF)

Effects of gamma-irradation on leishmania mexicana parasites and their use as a live vaccine

Birkett, Sally Jo

2010

Volltextzugriff (PDF)

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

British journal of clinical pharmacology, 1998-06, Vol.45 (6), p.525-538

1998

Volltextzugriff (PDF)

Nonspecific binding of drugs to human liver microsomes

British journal of clinical pharmacology, 2000-05, Vol.49 (5), p.453-461

2000

Volltextzugriff (PDF)

Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2

The Journal of pharmacology and experimental therapeutics, 1993-04, Vol.265 (1), p.401

1993

Volltextzugriff (PDF)

The xenobiotic inhibitor profile of cytochrome P4502C8

British journal of clinical pharmacology, 2000-12, Vol.50 (6), p.573-580

2000

Volltextzugriff (PDF)

Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism

British journal of clinical pharmacology, 1993-12, Vol.36 (6), p.521-530

1993

Volltextzugriff (PDF)

Caffeine metabolism by human hepatic cytochromes p450: Contributions of 1A2, 2E1 and 3A isoforms

Biochemical pharmacology, 1994-05, Vol.47 (10), p.1767-1776

1994

Volltextzugriff (PDF)

Polymorphic hydroxylation of perhexiline in vitro

British journal of clinical pharmacology, 2003-06, Vol.55 (6), p.635-638

2003

Volltextzugriff (PDF)

Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism

British journal of clinical pharmacology, 1994-06, Vol.37 (6), p.597-604

1994

Volltextzugriff (PDF)

Diazepam metabolism by human liver microsomes is mediated by both S‐ mephenytoin hydroxylase and CYP3A isoforms

British journal of clinical pharmacology, 1994-08, Vol.38 (2), p.131-137

1994

Volltextzugriff (PDF)

Differential Contribution of Active Site Residues in Substrate Recognition Sites 1 and 5 to Cytochrome P450 2C8 Substrate Selectivity and Regioselectivity

Biochemistry (Easton), 2004-06, Vol.43 (24), p.7834-7842

2004

Volltextzugriff (PDF)

[15] Use of tolbutamide as a substrate probe for human hepatic cytochrome P450 2C9

Methods in Enzymology, 1996, Vol.272, p.139-145

1996

Volltextzugriff (PDF)

Cytochromes P450, 1A2, and 2C9 are responsible for the human hepatic O-demethylation of R- and S-naproxen

Biochemical pharmacology, 1996-04, Vol.51 (8), p.1003-1008

1996

Volltextzugriff (PDF)

Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques

Biochemical pharmacology, 1993-12, Vol.46 (11), p.1975-1981

1993

Volltextzugriff (PDF)

Site-directed mutation studies of human liver cytochrome P-450 isoenzymes in the CYP2C subfamily

Biochemical journal, 1993-01, Vol.289 (2), p.533-538

1993

Volltextzugriff (PDF)

Evidence for involvement of human CYP3A in the 3‐hydroxylation of quinine

British journal of clinical pharmacology, 1997-03, Vol.43 (3), p.245-252

1997

Volltextzugriff (PDF)

Human hepatic cytochrome P450 2C9 catalyzes the rate-limiting pathway of torsemide metabolism

The Journal of pharmacology and experimental therapeutics, 1995-03, Vol.272 (3), p.1076

1995

Volltextzugriff (PDF)

Optimizing bacterial expression of catalytically active human cytochromes P450: comparison of CYP2C8 and CYP2C9

Xenobiotica, 2004, Vol.34 (1), p.49-60

2004

Volltextzugriff (PDF)

In vitro approaches can predict human drug metabolism

Trends in pharmacological sciences (Regular ed.), 1993-08, Vol.14 (8), p.292-294

1993

Volltextzugriff (PDF)

Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects

British journal of clinical pharmacology, 1996-04, Vol.41 (4), p.299-304

1996

Volltextzugriff (PDF)

Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9

Biochemical and biophysical research communications, 1991-03, Vol.175 (3), p.1112-1118

1991

Volltextzugriff (PDF)

Validation of the tolbutamide metabolic ratio for population screening with use of sulfaphenazole to produce model phenotypic poor metabolizers

Clinical pharmacology and therapeutics, 1990-03, Vol.47 (3), p.403-411

1990

Volltextzugriff (PDF)

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(74)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(85)
Humans
(81)
Life Sciences & Biomedicine
(79)
Pharmacology & Pharmacy
(70)
Biological And Medical Sciences
(58)
Medical Sciences
(53)
Pharmacology. Drug Treatments
(49)
Male
(42)
Adult
(38)
Kinetics
(31)
Cytochrome P-450 Enzyme System - Metabolism
(30)
Female
(27)
Microsomes, Liver - Enzymology
(22)
Microsomes, Liver - Metabolism
(18)
In Vitro Techniques
(17)
General Pharmacology
(15)
Aryl Hydrocarbon Hydroxylases
(14)
Theophylline - Metabolism
(14)
Animals
(13)
Hydroxylation
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Understanding how doctoral researchers perceive research supervision to impact their mental health and well‐being

Decolonising the Psychology Curriculum: A Toolkit Approach

Effects of gamma-irradation on leishmania mexicana parasites and their use as a live vaccine

Cytochrome P4502C9: an enzyme of major importance in human drug metabolism

Nonspecific binding of drugs to human liver microsomes

Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2

The xenobiotic inhibitor profile of cytochrome P4502C8

Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism

Caffeine metabolism by human hepatic cytochromes p450: Contributions of 1A2, 2E1 and 3A isoforms

Polymorphic hydroxylation of perhexiline in vitro

Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism

Diazepam metabolism by human liver microsomes is mediated by both S‐ mephenytoin hydroxylase and CYP3A isoforms

Differential Contribution of Active Site Residues in Substrate Recognition Sites 1 and 5 to Cytochrome P450 2C8 Substrate Selectivity and Regioselectivity

Primary structure and functional expression of rat and human stem cell factor DNAs

[15] Use of tolbutamide as a substrate probe for human hepatic cytochrome P450 2C9

Cytochromes P450, 1A2, and 2C9 are responsible for the human hepatic O-demethylation of R- and S-naproxen

Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques

Site-directed mutation studies of human liver cytochrome P-450 isoenzymes in the CYP2C subfamily

Evidence for involvement of human CYP3A in the 3‐hydroxylation of quinine

Human hepatic cytochrome P450 2C9 catalyzes the rate-limiting pathway of torsemide metabolism

Optimizing bacterial expression of catalytically active human cytochromes P450: comparison of CYP2C8 and CYP2C9

In vitro approaches can predict human drug metabolism

Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects

Tolbutamide and phenytoin hydroxylations by cDNA-expressed human liver cytochrome P4502C9

Validation of the tolbutamide metabolic ratio for population screening with use of sulfaphenazole to produce model phenotypic poor metabolizers

Suchergebnisse filtern